About Company
Sandoz Group AG, originally founded in 1886, has evolved into a prominent player in the healthcare sector, specializing in the development and production of high-quality generic and biosimilar medicines. The company aims to enhance patient access to affordable medications and is committed to delivering innovative solutions that meet healthcare needs worldwide. Following its spin-off from Novartis in 2023, Sandoz operates independently while continuing to uphold its legacy of quality and accessibility in pharmaceuticals.